Literature DB >> 7783869

Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study.

G P Jarvik1, E M Wijsman, W A Kukull, G D Schellenberg, C Yu, E B Larson.   

Abstract

OBJECTIVE: The joint effects of total cholesterol (TC) levels and the APOE genotype in Alzheimer's disease (AD) were evaluated because of previous reports that the APOE locus epsilon 4 allele was associated with both late-onset AD and elevated TC.
DESIGN: Logistic regression was used to determine the effects of the APOE genotype, TC, age, and sex on prediction of AD in a community-based study of 206 cases and 276 controls.
RESULTS: The relationship of the APOE genotype and AD was dependent on TC, age, and sex. However, current TC level does not fully explain the epsilon 4-Alzheimer's disease association. Affected men with higher TC and age under 80 years had the highest epsilon 4 allele frequencies. The epsilon 4 frequency declined significantly with age. SIGNIFICANCE: A pathologic role of higher TC or cholesterol-based differential survival of epsilon 4-carrying individuals may be involved in the relationship of the epsilon 4 allele with AD. The observed association of the APOE genotype and AD is expected to depend on the age, sex, and TC distributions of a given sample.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783869     DOI: 10.1212/wnl.45.6.1092

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  82 in total

1.  ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.

Authors:  Anne M Fagan; Erin Christopher; Jennie W Taylor; Maia Parsadanian; Michael Spinner; Melanie Watson; John D Fryer; Suzanne Wahrle; Kelly R Bales; Steven M Paul; David M Holtzman
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  Interactive effects of physical activity and APOE-ε4 on BOLD semantic memory activation in healthy elders.

Authors:  J Carson Smith; Kristy A Nielson; John L Woodard; Michael Seidenberg; Sally Durgerian; Piero Antuono; Alissa M Butts; Nathan C Hantke; Melissa A Lancaster; Stephen M Rao
Journal:  Neuroimage       Date:  2010-08-05       Impact factor: 6.556

Review 4.  Type 2 diabetes mellitus, dyslipidemia, and Alzheimer's disease.

Authors:  Cynthia M Carlsson
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 6.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

7.  Age-related influence of the HDL receptor SR-BI on synaptic plasticity and cognition.

Authors:  Eric H Chang; Attilio Rigotti; Patricio T Huerta
Journal:  Neurobiol Aging       Date:  2007-08-23       Impact factor: 4.673

Review 8.  Dyslipidemia and the risk of Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Curr Atheroscler Rep       Date:  2013-03       Impact factor: 5.113

Review 9.  Statins and dementia.

Authors:  Lewis H Kuller
Journal:  Curr Atheroscler Rep       Date:  2007-08       Impact factor: 5.113

Review 10.  Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease.

Authors:  Mark Burns; Karen Duff
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.